Liver Resection with Portal Vein Thrombectomy for Hepatocellular Carcinoma With Vascular Invasion-Reference-Cited by-同舟云学术

Liver Resection with Portal Vein Thrombectomy for Hepatocellular Carcinoma With Vascular Invasion

Published:2009-03-10 Issue:5 Volume:16 Page:1254-1254
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Aldrighetti Luca,Pulitanò Carlo,Catena Marco,Arru Marcella,Guzzetti Eleonora,Halliday Jane,Ferla Gianfranco

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-009-0383-y.pdf

Reference5 articles.

1. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology. 1999;29: 62–7.

2. Ikai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy Ann Surg. 1998; 227:433–9.

3. Chen XP, Qiu FZ, Wu ZD, et al. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma Ann Surg Oncol. 2006;13: 940–6.

4. Le Treut YP, Hardwigsen J, Ananian P, et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series J Gastrointest Surg. 2006;10:855–62.

5. Peng B, Liang L, He Q, Zhou F, Luo S. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus Hepatogastroenterology. 2006;53:415–9.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of MED7 was associated with progression in hepatocellular carcinoma;Cancer Biomarkers;2023-12-15

2. METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment;Scientific Reports;2023-07-03

3. lncRNA PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD;Aging;2023-03-02

4. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner;Experimental Hematology & Oncology;2023-01-06

5. Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells;Journal of Chemotherapy;2022-11-11